These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38754721)

  • 1. Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders.
    Chandel P; Thapa K; Kanojia N; Rani L; Singh TG; Rohilla P
    Neuroscience; 2024 Jul; 551():69-78. PubMed ID: 38754721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication.
    Jaberi KR; Alamdari-Palangi V; Savardashtaki A; Vatankhah P; Jamialahmadi T; Tajbakhsh A; Sahebkar A
    Curr Dev Nutr; 2024 Jun; 8(6):103785. PubMed ID: 38939650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health.
    Cocean AM; Vodnar DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111073. PubMed ID: 38914414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gut microbiota in the pathophysiology of mental and neurological disorders.
    Pusceddu MM; Del Bas JM
    Psychiatr Genet; 2020 Aug; 30(4):87-100. PubMed ID: 32459708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.
    Socała K; Doboszewska U; Szopa A; Serefko A; Włodarczyk M; Zielińska A; Poleszak E; Fichna J; Wlaź P
    Pharmacol Res; 2021 Oct; 172():105840. PubMed ID: 34450312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphenols in the management of brain disorders: Modulation of the microbiota-gut-brain axis.
    Serra D; Almeida LM; Dinis TCP
    Adv Food Nutr Res; 2020; 91():1-27. PubMed ID: 32035595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
    Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
    Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in neurological diseases: Melatonin plays an important regulatory role.
    Ahmadi S; Taghizadieh M; Mehdizadehfar E; Hasani A; Khalili Fard J; Feizi H; Hamishehkar H; Ansarin M; Yekani M; Memar MY
    Biomed Pharmacother; 2024 May; 174():116487. PubMed ID: 38518598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal flora and neurological disorders].
    Tang Q; Cao L
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3757-3780. PubMed ID: 34841782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders.
    Warner BB
    Pediatr Res; 2019 Jan; 85(2):216-224. PubMed ID: 30283047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders.
    Borrego-Ruiz A; Borrego JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110861. PubMed ID: 37690584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis.
    Dai H; Jiang Y; Liu S; Li D; Zhang X
    Food Res Int; 2024 Jun; 186():114404. PubMed ID: 38729686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A systematic review.
    Chatterjee A; Kumar S; Roy Sarkar S; Halder R; Kumari R; Banerjee S; Sarkar B
    J Nutr Biochem; 2024 Jul; 129():109622. PubMed ID: 38490348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiota-brain axis in neurological disorder.
    Ullah H; Arbab S; Tian Y; Liu CQ; Chen Y; Qijie L; Khan MIU; Hassan IU; Li K
    Front Neurosci; 2023; 17():1225875. PubMed ID: 37600019
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lei W; Cheng Y; Gao J; Liu X; Shao L; Kong Q; Zheng N; Ling Z; Hu W
    Front Cell Infect Microbiol; 2023; 13():1224155. PubMed ID: 37492530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the microbiota in pharmacology of psychiatric disorders.
    Pascale A; Marchesi N; Govoni S; Barbieri A
    Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.